16-hydroxy-5,8,11,14-eicosatetraenoic acid and Apoplexy

16-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Apoplexy in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahern, TP; Balazy, M; Bednar, MM; Falck, JR; Fuller, SP; Gross, CE; Howard, DB; Reddy, KM; Russell, SR	1

Other Studies

1 other study(ies) available for 16-hydroxy-5,8,11,14-eicosatetraenoic acid and Apoplexy

Article	Year
16(R)-hydroxyeicosatetraenoic acid, a novel cytochrome P450 product of arachidonic acid, suppresses activation of human polymorphonuclear leukocyte and reduces intracranial pressure in a rabbit model of thromboembolic stroke. Neurosurgery, 2000, Volume: 47, Issue:6 Topics: Animals; Arachidonic Acid; Cell Adhesion; Cell Aggregation; Cytochrome P-450 Enzyme System; Drug Synergism; Fibrinolytic Agents; Humans; Hydroxyeicosatetraenoic Acids; Intracranial Embolism and Thrombosis; Intracranial Pressure; Leukotriene B4; Neutrophils; Rabbits; Single-Blind Method; Stroke; Tissue Plasminogen Activator	2000

Article

Year

16(R)-hydroxyeicosatetraenoic acid, a novel cytochrome P450 product of arachidonic acid, suppresses activation of human polymorphonuclear leukocyte and reduces intracranial pressure in a rabbit model of thromboembolic stroke.

Neurosurgery, 2000, Volume: 47, Issue:6

Topics: Animals; Arachidonic Acid; Cell Adhesion; Cell Aggregation; Cytochrome P-450 Enzyme System; Drug Synergism; Fibrinolytic Agents; Humans; Hydroxyeicosatetraenoic Acids; Intracranial Embolism and Thrombosis; Intracranial Pressure; Leukotriene B4; Neutrophils; Rabbits; Single-Blind Method; Stroke; Tissue Plasminogen Activator

2000